Purchase Order 75P00220P00148
Award Date 6/30/20
Potential Completion Date 7/30/20
Potential Value $1.2M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Summit, NJ 07901, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Health and Human Services has awarded a $22,428.00 firm-fixed-price purchase order contract to Seqirus USA Inc., a global biotechnology company, for the delivery of flu vaccines during the 2024-2025 season. This award is not a set-aside contract. Seqirus, through its Seqirus Usa, Inc. division, is a major supplier of influenza vaccines to various federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of Health and Human...
- This federal contract award was issued by the Department of Health and Human Services (HHS) to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $940,522.50 firm fixed price purchase order is for the delivery of flu vaccines. Seqirus USA Inc. has previously received awards from other federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of Justice Bureau of Prisons, and the Centers for Disease Control and...
- This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccines. The contract is for the delivery of flu vaccines, with a potential value of $227,430.00. Seqirus USA Inc. has previously received contracts from various government agencies, including the Department of Defense, Department of Justice Bureau of Prisons, and Department of Health and...
- The U.S. federal government has awarded a $141,185 delivery order contract to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development, manufacturing, and delivery. The contract, with a performance period ending on August 30, 2024, is for the supply of influenza virus vaccines. Seqirus USA Inc. is the prime contractor and will be delivering the vaccines under this firm-fixed-price contract. This award is not associated with a set-aside program. Seqirus USA...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to Seqirus USA Inc., a division of Seqirus USA, Inc., to provide flu vaccines. The contract has a potential value of $109,410.00 and a completion date of October 31, 2018. Seqirus USA, Inc. is a global biotechnology company that specializes in influenza vaccines and has held several active Indefinite Delivery Indefinite Quantity (IDIQ) contracts to provide vaccines to various...
- This is a $10,091,030 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Seqirus USA Inc. for the delivery of influenza virus vaccines. The contract has a period of performance through September 27, 2024. Seqirus is a global biotechnology company that specializes in the development and delivery of influenza vaccines. The company has been awarded numerous federal contracts and delivery orders to provide influenza vaccines to various...
- This federal contract award, valued at $1,754,655.00, was issued by the Defense Logistics Agency Troop Support Medical to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccine development and production. The contract is a Delivery Order under a broader Indefinite Delivery Indefinite Quantity (IDIQ) contract, with a firm fixed price pricing type and an ultimate completion date of September 27, 2024. Seqirus USA Inc. has been awarded numerous federal contracts to...
- This contract was awarded by the Centers for Disease Control and Prevention (CDC), an agency within the U.S. Department of Health and Human Services, to Seqirus USA Inc. through its Seqirus Usa, Inc. Division. The contract, valued at $23,480,000.00, is for the delivery of ADULT FLU vaccines. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and the Ultimate Completion Date is February 28, 2019. The contract is not designated as a set-aside. Seqirus USA Inc. is a...
- This is a Definitive Contract award from the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc., a foreign-owned for-profit organization, for the provision of influenza vaccines. The contract, valued at $309,633.70, is a Firm Fixed Price award without any set-aside designation. Seqirus USA Inc., through its Seqirus USA, Inc. division, will deliver influenza vaccines in various formulations to support annual flu vaccination programs for federal government populations,...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $187,670.00 contract is for the delivery of flu vaccines, with a completion date of October 15, 2018. Seqirus USA Inc. is the prime contractor and no set-aside was used for this award. Seqirus USA Inc. is a division of Seqirus Usa, Inc. and has a history of providing influenza...